Ligand validation:1UH5

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1UH5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1UH5_NAD_B_601	69%	8%	0.127	0.941	2.73	2.16	10	12	0	0	100%	1
1UH5_NAD_A_501	32%	7%	0.187	0.861	2.8	2.16	12	11	0	0	100%	1
2OL4_NAD_B_451	92%	35%	0.079	0.969	1.3	1.35	5	8	0	0	100%	1
4IGE_NAD_B_502	90%	27%	0.088	0.971	1.65	1.42	5	4	0	0	100%	1
2OOS_NAD_A_450	88%	40%	0.096	0.971	1.01	1.39	3	3	0	0	100%	1
4IGF_NAD_B_502	87%	25%	0.104	0.978	1.73	1.5	4	5	1	0	100%	1
2O2Y_NAD_C_750	86%	29%	0.094	0.964	1.65	1.31	3	4	0	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.